The rise in the prevalence of cancer across the globe and growing awareness of immune checkpoint inhibitors propel product demand. Also, technological developments in screening procedures for cancer, an increase in government initiatives to cure cancer, growing healthcare expenditures, and rise in public awareness further boost the market growth. However, the high cost associated with research activities will likely restrain the industry's growth.

Category
Country

Similar Articles

Similar Bookmarks

Connected Bookmarks